Evernorth Health Services said its Accredo arm will make a Humira biosimilar available to patients with no out-of-pocket ...

In late 2022, Cigna's Evernorth unit made a $2.5 billion investment in VillageMD, and gained a minority stake in the primary ...

Cigna reported a $300 million first quarter loss as the company grapples with the loss in value of its investment in ...

The Windsor Improvement Corporation generously donated the land for this project and garnered widespread community support to ...

Q1 results reflect strong organic growth in the Evernorth Health Services unit. It expects adjusted EPS of at least $28.40 ...

Cigna Group is one step closer to divesting its Medicare Advantage business, which will shield the company from sector ...

To help achieve those savings, it is important to make sure patients are supported and their experience is seamless," said Matt Perlberg, president of Evernorth Health Services' pharmacy and care ...

Improving the Patient Financial Experience Throughout the Patient Journey While many healthcare providers believe that improving the patient financial experience is a critical step for their ...

Evernorth Health Services will offer Humira biosimilar products with no out-of-pocket cost through its Accredo specialty ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...